Subject: FOR INFORMATION: Update to integrated reporting protocol and metadata
From: "ECDC respiratory viruses" <[email-masked]>
Cc: "ECDC Info" <[email-masked]>
Date: Mon, 15 Dec 2025 14:50:13 +0200

Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu 
saatja korral palume linke ja faile mitte avada.

To:  National Focal Points for Viral Respiratory Diseases, Operational 
Contact Points (Epi, Micro, TESSy) for( Influenza, Covid-19, SARI) for 
ERVI-Net
Observer National Focal Points for Viral Respiratory Diseases (Enlargement 
Countries)
Contact Points for Operations (Epi, Micro, TESSy) for ( Influenza, Covid-19, 
SARI) for ERVI –Net (Enlargement Countries)

Cc:  National Coordinators, National Correspondents (Enlargement Countries)

Dear colleagues,

We have made several changes to the Integrated reporting protocol that 
affect the metadata for RESPISURV, SARISURV, and INFLANTIVIR.

This includes the following changes:

*	BrandLastCOVID19Dose and DrugProphylaxisRESPI coded value lists have been 
updated.
*	Influenza AntigenicGroup and GeneticClade coded value lists have been 
updated.
*	RSVVacProduct coded value list has been updated and expanded to include 
RSV monoclonal antibodies.
*	The descriptions of RSV vaccination status, date of RSV vaccine, and RSV 
vaccine product have been revised to reflect these changes, shifting from 
“vaccination” to “immunisation”.

The metadata and attached reporting protocol can be found as usual on TESSy. 
The reporting protocol is also published on the 
<https://urldefense.com/v3/__https:/www.ecdc.europa.eu/en/covid-19/surveillance/study-protocols__;!!CfJOjA!FWvy5LwkyLY20ICuHzM0aJQatMLw5Yg92cJH551m02N-UTsB2ovBZHvcNd0yfdQwsKUovjY0NeI341d8vG7dcAuX8Ngv61a-EmWWTqKn$> 
ECDC website.

Kind regards,

ECDC and WHO Europe respiratory virus surveillance teams

European Centre for Disease Prevention and Control (ECDC)

Gustav III:s boulevard 40, 169 73 Solna, Sweden

Phone +46 (0)8 58 60 10 00

www.ecdc.europa.eu

Follow ECDC on:

Classified as ECDC NORMAL 

Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly 
requested, to, consecutively, refrain from disclosing its content to any 
third party, delete it and inform its sender of the erroneous transmittal.

Classified as ECDC NORMAL